Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 15, 2011

View Archived Issues

ArQule and Daiichi Sankyo disclose preclinical findings on ARQ-092

New biomarker for dengue fever identified

Acasti Pharma begins second phase II CaPre study

New serine/threonine-protein kinase ATR inhibitors claimed

Second remissions evaluated in epratuzumab study in relapsed acute lymphoblastic leukemia

Paladin Labs launches product for digoxin toxicity and overdose in Canada

New glimepiride formulation launched in Japan

Neoprobe licenses imaging agent from AstraZeneca

Antitumor effects of K-560 evaluated in preclinical settings

Novel antimalarial is potent without inducing parasite dormancy

Researchers at Chemilia design new anticancer agents

New histamine H3 receptor modulators presented

Novel antibacterial and antifungal agents disclosed by A*STAR

Baxter International signs acquisition agreement

Tarsa Therapeutics plans NDA submission for oral recombinant calcitonin

FDA committee issues vote on Adasuve

Japanese phase II/III trial in osteoporosis meets primary endpoint

Simcere and Bristol-Myers Squibb extend partnership

OSI Pharmaceuticals presents new macrophage-stimulating protein receptor inhibitors

Pharmalink in-licenses Archimedes Pharma technology

Treatment begins in pivotal phase III CXA-201 trial

Avila Therapeutics product shows promise to treat hematological cancers

Bayer HealthCare submits applications for long-term contraceptive system

ATx08-001 study meets primary objectives

Zybrestat to be provided on a compassionate-use basis

Veregen mutual recognition approval process continues

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...